Giblin Jonathan P, Cui Yi, Clapp Lucie H, Tinker Andrew
Centre for Clinical Pharmacology, Department of Medicine, University College London, The Rayne Institute, London WC1E 6JJ, United Kingdom.
J Biol Chem. 2002 Apr 19;277(16):13717-23. doi: 10.1074/jbc.M112209200. Epub 2002 Feb 1.
ATP-sensitive potassium channels (K(ATP) channels) are formed from an octameric complex of an inwardly rectifying K(+) channel (Kir6.1, Kir6.2) and a sulfonylurea receptor (SUR1, SUR2A, and SUR2B). In this study we have attempted to address the question of whether SUR heteromultimers can form using a combination of biochemical and electrophysiological approaches. We have constructed monoclonal stable lines in HEK293 cells co-expressing Kir6.2 with SUR1 and SUR2A. Using coimmunoprecipitation analysis with SUR isotype-specific antibodies two biochemical populations are distinguished, one containing SUR1 and the other SUR2A. It is not possible to detect immune complexes containing both SUR1 and SUR2A. Functional studies were undertaken and whole cell membrane currents were studied using the patch clamp. Concentrations of sulfonylureas and potassium channel openers were determined that selectively inhibited or activated SUR1/Kir6.2 and SUR2A/Kir6.2. In the cell line expressing SUR1/SUR2AKir6.2 we were unable to demonstrate a population of channels with unique pharmacological properties. Thus we conclude from these studies that heteromultimeric channel complexes containing both SUR1 and SUR2A are not formed, suggesting an incompatibility between different SUR subtypes. This incompatibility limits the pharmacological complexity of K(ATP) channels that may be observed in native tissues.
ATP敏感性钾通道(K(ATP)通道)由内向整流钾通道(Kir6.1、Kir6.2)和磺脲类受体(SUR1、SUR2A和SUR2B)的八聚体复合物形成。在本研究中,我们试图通过结合生化和电生理方法来解决SUR异源多聚体是否能够形成的问题。我们在共表达Kir6.2与SUR1和SUR2A的HEK293细胞中构建了单克隆稳定细胞系。使用SUR同种型特异性抗体进行共免疫沉淀分析,区分出两个生化群体,一个含有SUR1,另一个含有SUR2A。无法检测到同时含有SUR1和SUR2A的免疫复合物。进行了功能研究,并使用膜片钳研究了全细胞膜电流。确定了选择性抑制或激活SUR1/Kir6.2和SUR2A/Kir6.2的磺脲类药物和钾通道开放剂的浓度。在表达SUR1/SUR2A-Kir6.2的细胞系中,我们无法证明存在具有独特药理学特性的通道群体。因此,我们从这些研究中得出结论,不形成同时含有SUR1和SUR2A的异源多聚体通道复合物,这表明不同SUR亚型之间存在不相容性。这种不相容性限制了在天然组织中可能观察到的K(ATP)通道的药理学复杂性。